PHVS – pharvaris n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
Pharvaris to Participate in the Leerink Partners Global Healthcare Conference 2025 [Yahoo! Finance]
Pharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and Treatment of HAE Attacks at the 2025 AAAAI/WAO Joint Congress [Yahoo! Finance]
Pharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and Treatment of HAE Attacks at the 2025 AAAAI/WAO Joint Congress
Pharvaris to Participate in the Leerink Partners Global Healthcare Conference 2025
Pharvaris (NASDAQ: PHVS) had its price target raised by analysts at JMP Securities from $46.00 to $55.00. They now have a "market outperform" rating on the stock.
Form 6-K Pharvaris N.V. For: Jan 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.